Prevacid, Lansoprazole News

Fast-Track peer review is available for those papers requiring immediate review .

Nursingcenter.com Exclusively searches the complete text articles from the 50 leading nursing journals available on NursingCenter, including more than 900 continuing education activities, clinical resources and drug updates contained within this website.

Increasing resistance to clarithromycin and nitroimidazole is the main cause of failure in the Helicobacter pylori eradication.

Below is a summary of updates to the BioMedReports.com database of over 200 entries included in the FDA and Clinical Trial Calendars .

Novartis has announced that Prevacid 24HR has been approved by the FDA as the first OTC Proton Pump Inhibitor for the treatment of frequent heartburn since 2003.

Lansoprazole is a proton pump inhibitor which powerfully suppresses gastric acid production and is widely prescribed for chronic use in gastroesophageal reflux disease.

A new study has added to the concern that commonly used proton-pump inhibitors may interfere with Plavix in people who have coronary artery disease.

Company Limited today announced the integration of its wholly owned subsidiaries Takeda Ireland Limited and Takeda Pharma Ireland Limited into a single operation on July 1, 2009, through a complete transfer of TPI's assets to TIL.

Four of the most commonly prescribed heartburn medications reduce the benefit associated with clopidogrel, a widely used antiplatelet medication also known by its brand name, Plavix.

Washington, May 7 : Scientists have found that the medicines used for the treatment of heartburn and ulcers can reduce the anti-clotting action of the medication clopidogrel, thereby resulting in about 50 per cent increase in the combined risk of hospitalisation for heart attack, stroke, and other serious cardiovascular illnesses.

In a new study, published in the May issue of Elsevier's Experimental Neurology, scientists at the University of British Columbia have discovered that drugs commonly used to treat ulcers have significant neuroprotective properties, which appear to be enhanced when used in combination with ibuprofen, a widely used anti-inflammatory drug.

PATIENTS WHO are given clopidogrel after a heart attack are at significantly higher risk for another one if they take most proton pump inhibitors to manage their stomach acid, according to a recent study published online by the Canadian Medical Association Journal.

The latest Journal of Pediatrics assesses the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.

Published: Tuesday, March 31, 2009 at 1:00 a.m. Last Modified: Monday, March 30, 2009 at 4:10 p.m. Dear Dr.

For treatment of active duodenal ulcer and maintenance treatment of healed duodenal ulcers.

Q: Can Prilosec interfere with Plavix? A: We don't know yet, but there is some concern that certain drugs known as proton pump inhibitors may make Plavix less effective.

In patients with gastroesophageal reflux disease , esomeprazole, has demonstrated pharmacological and clinical benefits beyond those seen with the other proton pump inhibitors .

A study by researchers at the Institute for Clinical Evaluative Sciences in Toronto, appears to indicate that the use of clopidogrel in combination with some proton pump inhibitors can increase the risk of ...

Main Category: Acid Reflux / GERD Also Included In: Medical Devices / Diagnostics Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today ...

DEERFIELD, Ill., and OSAKA, Japan, Jan 30, 2009 /PRNewswire via COMTEX/ -- First proton pump inhibitor with a Dual Delayed Release formulation Takeda Pharmaceutical Company Limited and its wholly-owned ...